Lin et al. identified a relationship between short telomeres and depressive symptoms in conjunction with increased bladder cancer mortality [16], and Yu et al. further observed that short telomeres, combined with GSTM1 homologous deletion, heightened bladder cancer risk [17]. Here, GSTM1 is linked to urinary bladder carcinoma.